These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31928227)

  • 21. Automated combustion accelerator mass spectrometry for the analysis of biomedical samples in the low attomole range.
    van Duijn E; Sandman H; Grossouw D; Mocking JA; Coulier L; Vaes WH
    Anal Chem; 2014 Aug; 86(15):7635-41. PubMed ID: 25033319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I, open-label, single-dose micro tracer mass balance study of
    Miyatake D; Nakada N; Takada A; Kato K; Taniuchi Y; Katashima M; Sawamoto T
    Drug Metab Pharmacokinet; 2018 Apr; 33(2):118-124. PubMed ID: 29606543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel use of cavity ring-down spectroscopy to investigate aquatic carbon cycling from microbial to ecosystem scales.
    Maher DT; Santos IR; Leuven JR; Oakes JM; Erler DV; Carvalho MC; Eyre BD
    Environ Sci Technol; 2013 Nov; 47(22):12938-45. PubMed ID: 24131451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extracts.
    Garner RC; Barker J; Flavell C; Garner JV; Whattam M; Young GC; Cussans N; Jezequel S; Leong D
    J Pharm Biomed Anal; 2000 Dec; 24(2):197-209. PubMed ID: 11130199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of 14C-labeled atrazine metabolites in human urine.
    Gilman SD; Gee SJ; Hammock BD; Vogel JS; Haack K; Buchholz BA; Freeman SP; Wester RC; Hui X; Maibach HI
    Anal Chem; 1998 Aug; 70(16):3463-9. PubMed ID: 9726169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of induction module cavity ring-down spectroscopy (IM-CRDS) for measuring δ
    Johnson JE; Hamann L; Dettman DL; Kim-Hak D; Leavitt SW; Monson RK; Papuga SA
    Rapid Commun Mass Spectrom; 2017 Mar; 31(6):547-560. PubMed ID: 28010033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mini-Review: Comprehensive Drug Disposition Knowledge Generated in the Modern Human Radiolabeled ADME Study.
    Spracklin DK; Chen D; Bergman AJ; Callegari E; Obach RS
    CPT Pharmacometrics Syst Pharmacol; 2020 Aug; 9(8):428-434. PubMed ID: 32562380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitor.
    Garner RC; Goris I; Laenen AA; Vanhoutte E; Meuldermans W; Gregory S; Garner JV; Leong D; Whattam M; Calam A; Snel CA
    Drug Metab Dispos; 2002 Jul; 30(7):823-30. PubMed ID: 12065441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double Trap Interface: A novel gas interface for high throughput analysis of biomedical samples by AMS.
    De Maria D; Fahrni SM; Lozac'h F; Marvalin C; Walles M; Camenisch G; Wacker L; Synal HA
    Drug Metab Pharmacokinet; 2021 Aug; 39():100400. PubMed ID: 34146821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of (14)C-accelerator MS in pharmaceutical development.
    Young GC; Seymour M
    Bioanalysis; 2015; 7(5):513-7. PubMed ID: 25826133
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach.
    Flach S; Croft M; Ding J; Budhram R; Pankratz T; Pennick M; Scarfe G; Troy S; Getsy J
    Drug Des Devel Ther; 2016; 10():3125-3132. PubMed ID: 27729771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Comparison of Cavity Ring Down Spectrometry and Isotope Ratio Mass Spectrometry for Detection of Sugar Adulteration in Honey Samples.
    Mantha M; Urban JR; Mark WA; Chernyshev A; Kubachka KM
    J AOAC Int; 2018 Nov; 101(6):1857-1863. PubMed ID: 29618406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accelerator MS: its role as a frontline bioanalytical technique.
    Seymour MA
    Bioanalysis; 2011 Dec; 3(24):2817-23. PubMed ID: 22185281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science.
    Malfatti MA; Buchholz BA; Enright HA; Stewart BJ; Ognibene TJ; McCartt AD; Loots GG; Zimmermann M; Scharadin TM; Cimino GD; Jonas BA; Pan CX; Bench G; Henderson PT; Turteltaub KW
    Toxics; 2019 May; 7(2):. PubMed ID: 31075884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economically Motivated Adulteration of Lemon Juice: Cavity Ring Down Spectroscopy in Comparison with Isotope Ratio Mass Spectrometry: Round-Robin Study.
    Mantha M; Kubachka KM; Urban JR; Dasenbrock CO; Chernyshev A; Mark WA; France C; Chartrand M; Hache J; Decoeur S; Qi H
    J AOAC Int; 2019 Sep; 102(5):1544-1551. PubMed ID: 30862326
    [No Abstract]   [Full Text] [Related]  

  • 36. Microdose pharmacogenetic study of ¹⁴C-tolbutamide in healthy subjects with accelerator mass spectrometry to examine the effects of CYP2C9∗3 on its pharmacokinetics and metabolism.
    Ikeda T; Aoyama S; Tozuka Z; Nozawa K; Hamabe Y; Matsui T; Kainuma M; Hasegawa S; Maeda K; Sugiyama Y
    Eur J Pharm Sci; 2013 Jul; 49(4):642-8. PubMed ID: 23727057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doubly labeled water analysis using cavity ring-down spectroscopy.
    Thorsen T; Shriver T; Racine N; Richman BA; Schoeller DA
    Rapid Commun Mass Spectrom; 2011 Jan; 25(1):3-8. PubMed ID: 21154648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a
    van Andel L; Rosing H; Zhang Z; Hughes L; Kansra V; Sanghvi M; Tibben MM; Gebretensae A; Schellens JHM; Beijnen JH
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):39-46. PubMed ID: 29043410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sample preparation for quantitation of tritium by accelerator mass spectrometry.
    Chiarappa-Zucca ML; Dingley KH; Roberts ML; Velsko CA; Love AH
    Anal Chem; 2002 Dec; 74(24):6285-90. PubMed ID: 12510750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the absorption of micronized (Daflon 500 mg) and nonmicronized 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting.
    Garner RC; Garner JV; Gregory S; Whattam M; Calam A; Leong D
    J Pharm Sci; 2002 Jan; 91(1):32-40. PubMed ID: 11782895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.